VITRAKVI caps 25 mg bte 56 pce
7680672810010
CH-67281
L01EX12
07.16.1.
Reimbursement limitations:
VITRAKVImono
Le traitement nécessite une garantie de prise en charge des frais par l’assureur-maladie après consultation …
1 / 3
google
Details
- Product number
- 6728101
- CPT
- -
- Packaging group
- 56
- Unit
- Kapsel(n)
- Composition
- larotrectinibum 25 mg ut larotrectinibi sulfas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 132, E 171, propylenglycolum, dimeticonum 1000, pro capsula.
Articles (1)
Vitrakvi 25 mg, Kapseln
Kapseln
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1485.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2022
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 67281
- Drug name
- Vitrakvi, Kapseln
- Galenic form
- KAPS
- ATC Code
- L01EX12
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/05/2020
- Authorization expiration date
- 19/02/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VITRAKVI caps 25 mg bte 56 pce
- Description (DE)
- VITRAKVI Kaps 25 mg Ds 56 Stk
- Market launch
- 28/05/2020
- Narcotic (BTM)
- No